Insider Trading activities at Dragon Pharmaceutical Inc (DRUG)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dragon Pharmaceutical Inc (DRUG) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dragon Pharmaceutical Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1075206.

Total stock buying since 2010: $0.
Total stock sales since 2010: $0.
Total stock option exercises since 2010: $765,000.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


4 insiders reported insider trading activities at Dragon Pharmaceutical Inc (DRUG):
Insider trading activities of Frey Heinz
Insider trading activities of Sun Yiu Kwong
Insider trading activities of Wick Alexander
Insider trading activities of Mak Peter

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Dragon Pharmaceutical Inc (DRUG).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2010 0 $0 0 $0 1,500,000 $765,000

Table 2. Monthly summary of insider trading at Dragon Pharmaceutical Inc (DRUG).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-05 0 $0 0 $0 1,500,000 $765,000

Table 3. Detailed insider trading at Dragon Pharmaceutical Inc (DRUG)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-05-17 Frey Heinz Option Ex 400,000 .51 204,000
2010-05-17 Mak Peter Option Ex 500,000 .51 255,000
2010-05-17 Sun Yiu Kwong Option Ex 300,000 .51 153,000
2010-05-17 Wick Alexander Option Ex 300,000 .51 153,000

Insider trading activities including stock purchases, stock sales, and option exercises of DRUG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dragon Pharmaceutical Inc (symbol DRUG, CIK number 1075206) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.